Phio Pharmaceuticals Corp..
PHIO.US | Research and experimental development on natural sciences and engineering
Phio Pharmaceuticals Corp. is a biotechnology company focused on developing immuno-oncology therapeutics. The company's primary focus is on using its self-delivering RNAi (sd-rxRNA®) technology platform to develop compounds that target the immune system to fight cancer. Their lead programs involve s...Show More
Better Health for All
0
No evidence available to assess Phio Pharmaceuticals Corp. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Phio Pharmaceuticals Corp. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific quantitative data was found in the provided articles to assess Phio Pharmaceuticals Corp. against the defined KPIs for Fair Pay & Worker Respect. Information regarding living wage coverage, CEO to median pay ratio, collective bargaining share, safety incident rate, pay equity ratio, worker engagement score, voluntary turnover rate, labor violation incidents, insecure contract share, or health insurance coverage for the workforce was not explicitly available or quantifiable according to the rubric's requirements.
1
While CEO compensation for 2023 was provided, the median employee compensation or the pay ratio itself was not available.
2
Employee headcount data was present, but not voluntary turnover rates.
3
Qualitative employee feedback was noted, but not a quantitative engagement score.
4
Details on one executive's benefits were provided, but not the percentage of the entire workforce covered by health insurance or on insecure contracts.
5
Fair Trade & Ethical Sourcing
0
Phio Pharmaceuticals Corp. focuses on research and development and does not manufacture or distribute pharmaceutical products.
1
As such, the company does not procure or trade physical commodities, nor does it have a supplier base requiring welfare or sourcing audits related to physical goods.
2
Consequently, there is no exposure to upstream labor practices, no supply chain tiers to map for physical products, and no remediation processes required for supply chain violations related to physical goods.
3
Similarly, there are no supplier contracts in scope for ethical sourcing of physical goods, and no material sourcing of at-risk inputs.
4
No information is available regarding procurement budget directed to diverse suppliers.
5
Honest & Fair Business
-40
Phio Pharmaceuticals Corp. has a formal whistleblower protection policy that encourages anonymous reporting to a Compliance Officer, providing a phone number and email.
1
However, there is no evidence regarding independent investigation processes for these reports. The company also has policies addressing anti-corruption and anti-bribery, including specific rules for gifts, meals, entertainment, and interactions with government officials, as well as rules regarding foreign bribery.
2
The evidence does not specify the frequency or effectiveness of training for these anti-corruption policies.
Kind to Animals
0
The provided articles do not contain specific information regarding Phio Pharmaceuticals Corp.'s animal welfare practices, policies, or performance. discusses general FDA plans and legislative proposals related to animal testing, but these are not specific to PHIO.US. The content of was not accessible.
1
No War, No Weapons
0
The provided articles, including a press release, a code of ethics, and an R&D summary, do not contain any specific, concrete data points or information relevant to the 'No War, No Weapons' ethical value or its associated KPIs.
1
All articles explicitly state that no quantitative data, regulatory actions, certifications, or comparisons related to these metrics are present.
2
Planet-Friendly Business
-30
In 2023, the company's total Scope 1, 2, and 3 greenhouse gas emissions were 287.5 tCO₂e, with a projected decline to 244.4 tCO₂e in 2024, representing a 14.99% reduction.
1
The share of operational energy consumption sourced from renewables was 22.3% in 2023.
2
The company conducts environmental impact assessments quarterly, which equates to 4 assessments per year.
3
Respect for Cultures & Communities
0
No evidence available to assess Phio Pharmaceuticals Corp. on Respect for Cultures & Communities.
Safe & Smart Tech
0
Phio Pharmaceuticals Corp. reported no data breaches or incidents materially affecting its business strategy, results, or financial condition as of December 31, 2023.
1
The company requires onboarding and ongoing cybersecurity awareness training for employees.
2
It also reported no incidents of unauthorized data use.
3
The company employs a risk-based approach to third-party service providers and utilizes continuous monitoring for threats.
4
Periodic external reviews of its cybersecurity program are conducted.
5
Zero Waste & Sustainable Products
0
No evidence available to assess Phio Pharmaceuticals Corp. on Zero Waste & Sustainable Products.